series	seriesDescription	geoAreaCode	geoAreaName	value	time_detail	upperBound	lowerBound	basePeriod	source	footnotes	nature_code	nature_desc	units_code	units_desc	reportingType_code	reportingType_desc	timePeriod	value_detail	lowerBound_detail	upperBound_detail	level	parentCode	parentName	type	X	Y	ISO3	UN_Member	Country_Profile
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	1	World	3.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				1			Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	1	World	4.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				1			Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	1	World	5.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				1			Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	1	World	7.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				1			Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	1	World	7.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				1			Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	1	World	8.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				1			Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	1	World	11.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				1			Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	1	World	11.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				1			Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	1	World	12.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				1			Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	100	Bulgaria	29.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	151	Eastern Europe	Country	25.23763153	42.75731323	BGR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	100	Bulgaria	14.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	151	Eastern Europe	Country	25.23763153	42.75731323	BGR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	100	Bulgaria	4.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	151	Eastern Europe	Country	25.23763153	42.75731323	BGR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	100	Bulgaria	3.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	151	Eastern Europe	Country	25.23763153	42.75731323	BGR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	100	Bulgaria	3.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	151	Eastern Europe	Country	25.23763153	42.75731323	BGR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	100	Bulgaria	5.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	151	Eastern Europe	Country	25.23763153	42.75731323	BGR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	11	Western Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	11	Western Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	11	Western Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	11	Western Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	11	Western Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	11	Western Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	11	Western Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	11	Western Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	11	Western Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	124	Canada	72.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	21	Northern America	Country	-101.6575058	57.72360191	CAN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	124	Canada	73.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	21	Northern America	Country	-101.6575058	57.72360191	CAN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	124	Canada	75.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	21	Northern America	Country	-101.6575058	57.72360191	CAN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	124	Canada	83.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	21	Northern America	Country	-101.6575058	57.72360191	CAN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	13	Central America	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	13	Central America	2.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	13	Central America	5.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	13	Central America	70.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	13	Central America	70.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	13	Central America	66.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	13	Central America	73.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	13	Central America	75.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	13	Central America	78.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	135	Caucasus and Central Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	135	Caucasus and Central Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	135	Caucasus and Central Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	135	Caucasus and Central Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	135	Caucasus and Central Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	135	Caucasus and Central Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	135	Caucasus and Central Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	135	Caucasus and Central Asia	7.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	135	Caucasus and Central Asia	8.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	14	Eastern Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	14	Eastern Africa	2.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	14	Eastern Africa	2.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	14	Eastern Africa	2.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	14	Eastern Africa	2.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	14	Eastern Africa	2.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	14	Eastern Africa	6.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	14	Eastern Africa	8.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	14	Eastern Africa	12.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	142	Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	142	Asia	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	142	Asia	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	142	Asia	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	142	Asia	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	142	Asia	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	142	Asia	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	142	Asia	2.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	142	Asia	2.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	143	Central Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	143	Central Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	143	Central Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	143	Central Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	143	Central Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	143	Central Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	143	Central Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	143	Central Asia	9.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	143	Central Asia	9.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	144	Sri Lanka	66.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	34	Southern Asia	Country	80.70489654	7.614693343	LKA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	145	Western Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	145	Western Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	145	Western Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	145	Western Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	145	Western Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	145	Western Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	145	Western Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	145	Western Asia	2.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	145	Western Asia	2.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	15	Northern Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				3	2	Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	15	Northern Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				3	2	Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	15	Northern Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				3	2	Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	15	Northern Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				3	2	Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	15	Northern Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				3	2	Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	15	Northern Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				3	2	Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	15	Northern Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				3	2	Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	15	Northern Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				3	2	Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	15	Northern Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				3	2	Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	150	Europe	19.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	150	Europe	22.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	150	Europe	26.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	150	Europe	25.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	150	Europe	25.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	150	Europe	26.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	150	Europe	27.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	150	Europe	27.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	150	Europe	27.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	151	Eastern Europe	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	151	Eastern Europe	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	151	Eastern Europe	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	151	Eastern Europe	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	151	Eastern Europe	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	151	Eastern Europe	3.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	151	Eastern Europe	3.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	151	Eastern Europe	3.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	151	Eastern Europe	3.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	152	Chile	70.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				5	5	South America	Country	-71.23029019	-35.2652885	CHL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	152	Chile	73.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				5	5	South America	Country	-71.23029019	-35.2652885	CHL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	152	Chile	67.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				5	5	South America	Country	-71.23029019	-35.2652885	CHL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	152	Chile	74.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	5	South America	Country	-71.23029019	-35.2652885	CHL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	154	Northern Europe	52.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	154	Northern Europe	62.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	154	Northern Europe	74.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	154	Northern Europe	69.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	154	Northern Europe	69.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	154	Northern Europe	67.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	154	Northern Europe	70.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	154	Northern Europe	69.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	154	Northern Europe	75.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	155	Western Europe	16.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	155	Western Europe	18.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	155	Western Europe	22.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	155	Western Europe	19.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	155	Western Europe	20.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	155	Western Europe	20.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	155	Western Europe	23.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	155	Western Europe	23.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	155	Western Europe	23.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	17	Middle Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	17	Middle Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	17	Middle Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	17	Middle Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	17	Middle Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	17	Middle Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	17	Middle Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	17	Middle Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	17	Middle Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	170	Colombia	50.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				5	5	South America	Country	-73.07446751	3.888209046	COL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	170	Colombia	36.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				5	5	South America	Country	-73.07446751	3.888209046	COL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	170	Colombia	12.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				5	5	South America	Country	-73.07446751	3.888209046	COL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	170	Colombia	23.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				5	5	South America	Country	-73.07446751	3.888209046	COL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	170	Colombia	7.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				5	5	South America	Country	-73.07446751	3.888209046	COL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	170	Colombia	14.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				5	5	South America	Country	-73.07446751	3.888209046	COL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	170	Colombia	29.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	5	South America	Country	-73.07446751	3.888209046	COL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	18	Southern Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	18	Southern Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	18	Southern Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	18	Southern Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	18	Southern Africa	54.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	18	Southern Africa	54.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	18	Southern Africa	56.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	18	Southern Africa	52.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	18	Southern Africa	52.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	202	Sub-Saharan Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	184	Cook Islands	76.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				4	61	Polynesia	Country	-159.7711391	-21.22696458	COK	0	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	184	Cook Islands	99.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	61	Polynesia	Country	-159.7711391	-21.22696458	COK	0	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	184	Cook Islands	99.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	61	Polynesia	Country	-159.7711391	-21.22696458	COK	0	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	184	Cook Islands	99.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	61	Polynesia	Country	-159.7711391	-21.22696458	COK	0	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	184	Cook Islands	66.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	61	Polynesia	Country	-159.7711391	-21.22696458	COK	0	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	184	Cook Islands	99.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	61	Polynesia	Country	-159.7711391	-21.22696458	COK	0	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	184	Cook Islands	99.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	61	Polynesia	Country	-159.7711391	-21.22696458	COK	0	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	19	Americas	9.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	19	Americas	12.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	19	Americas	16.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	19	Americas	30.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	19	Americas	31.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	19	Americas	38.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	19	Americas	53.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	19	Americas	58.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	19	Americas	57.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	196	Cyprus	57.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	145	Western Asia	Country	33.22285964	35.05659437	CYP	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	196	Cyprus	63.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	145	Western Asia	Country	33.22285964	35.05659437	CYP	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	199	Least Developed Countries (LDC)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	199	Least Developed Countries (LDC)	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	199	Least Developed Countries (LDC)	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	199	Least Developed Countries (LDC)	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	199	Least Developed Countries (LDC)	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	199	Least Developed Countries (LDC)	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	199	Least Developed Countries (LDC)	2.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	199	Least Developed Countries (LDC)	4.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	199	Least Developed Countries (LDC)	5.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	2	Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	2	Africa	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	2	Africa	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	2	Africa	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	2	Africa	3.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	2	Africa	3.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	2	Africa	4.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	2	Africa	5.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	2	Africa	7.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	202	Sub-Saharan Africa	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				3	2	Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	202	Sub-Saharan Africa	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				3	2	Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	202	Sub-Saharan Africa	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				3	2	Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	202	Sub-Saharan Africa	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				3	2	Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	202	Sub-Saharan Africa	4.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				3	2	Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	202	Sub-Saharan Africa	4.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				3	2	Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	202	Sub-Saharan Africa	5.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				3	2	Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	202	Sub-Saharan Africa	6.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				3	2	Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	202	Sub-Saharan Africa	8.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				3	2	Africa	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	208	Denmark	69.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				4	154	Northern Europe	Country	9.326571283	56.03829721	DNK	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	208	Denmark	73.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	154	Northern Europe	Country	9.326571283	56.03829721	DNK	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	208	Denmark	78.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	154	Northern Europe	Country	9.326571283	56.03829721	DNK	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	208	Denmark	68.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	154	Northern Europe	Country	9.326571283	56.03829721	DNK	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	208	Denmark	57.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	154	Northern Europe	Country	9.326571283	56.03829721	DNK	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	208	Denmark	16.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	154	Northern Europe	Country	9.326571283	56.03829721	DNK	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	208	Denmark	36.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	154	Northern Europe	Country	9.326571283	56.03829721	DNK	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	208	Denmark	54.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	154	Northern Europe	Country	9.326571283	56.03829721	DNK	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	21	Northern America	29.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				3	19	Americas	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	21	Northern America	34.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				3	19	Americas	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	21	Northern America	32.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				3	19	Americas	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	21	Northern America	36.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				3	19	Americas	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	21	Northern America	38.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				3	19	Americas	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	21	Northern America	46.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				3	19	Americas	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	21	Northern America	48.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				3	19	Americas	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	21	Northern America	53.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				3	19	Americas	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	21	Northern America	49.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				3	19	Americas	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	214	Dominican Republic	31.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				5	29	Caribbean	Country	-70.49847576	18.89832088	DOM	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	214	Dominican Republic	5.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	29	Caribbean	Country	-70.49847576	18.89832088	DOM	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	218	Ecuador	72.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				5	5	South America	Country	-78.37005241	-1.447785891	ECU	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	218	Ecuador	8.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				5	5	South America	Country	-78.37005241	-1.447785891	ECU	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	218	Ecuador	93.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				5	5	South America	Country	-78.37005241	-1.447785891	ECU	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	218	Ecuador	99.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				5	5	South America	Country	-78.37005241	-1.447785891	ECU	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	218	Ecuador	90.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	5	South America	Country	-78.37005241	-1.447785891	ECU	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	233	Estonia	44.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	154	Northern Europe	Country	25.84093481	58.68487172	EST	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	242	Fiji	50.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	54	Melanesia	Country	177.9660884	-17.83301566	FJI	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	242	Fiji	48.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	54	Melanesia	Country	177.9660884	-17.83301566	FJI	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	242	Fiji	46.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	54	Melanesia	Country	177.9660884	-17.83301566	FJI	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	246	Finland	61.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	154	Northern Europe	Country	23.308447	61.91586738	FIN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	276	Germany	26.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				4	155	Western Europe	Country	10.3806066	51.08862743	DEU	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	276	Germany	26.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				4	155	Western Europe	Country	10.3806066	51.08862743	DEU	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	276	Germany	26.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	155	Western Europe	Country	10.3806066	51.08862743	DEU	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	276	Germany	29.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	155	Western Europe	Country	10.3806066	51.08862743	DEU	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	276	Germany	30.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	155	Western Europe	Country	10.3806066	51.08862743	DEU	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	276	Germany	31.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	155	Western Europe	Country	10.3806066	51.08862743	DEU	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	276	Germany	31.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	155	Western Europe	Country	10.3806066	51.08862743	DEU	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	276	Germany	31.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	155	Western Europe	Country	10.3806066	51.08862743	DEU	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	276	Germany	31.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	155	Western Europe	Country	10.3806066	51.08862743	DEU	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	29	Caribbean	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	29	Caribbean	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	29	Caribbean	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	29	Caribbean	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	29	Caribbean	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	29	Caribbean	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	29	Caribbean	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	29	Caribbean	10.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	29	Caribbean	3.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	30	Eastern Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	30	Eastern Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	30	Eastern Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	30	Eastern Asia	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	30	Eastern Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	30	Eastern Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	30	Eastern Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	30	Eastern Asia	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	30	Eastern Asia	2.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	32	Argentina	37.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				5	5	South America	Country	-65.14563274	-35.19446255	ARG	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	32	Argentina	56.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				5	5	South America	Country	-65.14563274	-35.19446255	ARG	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	32	Argentina	53.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				5	5	South America	Country	-65.14563274	-35.19446255	ARG	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	32	Argentina	47.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				5	5	South America	Country	-65.14563274	-35.19446255	ARG	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	32	Argentina	55.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				5	5	South America	Country	-65.14563274	-35.19446255	ARG	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	32	Argentina	48.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				5	5	South America	Country	-65.14563274	-35.19446255	ARG	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	32	Argentina	57.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	5	South America	Country	-65.14563274	-35.19446255	ARG	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	320	Guatemala	33.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	13	Central America	Country	-91.2312746	15.00273719	GTM	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	328	Guyana	9.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	5	South America	Country	-58.97322037	4.788012784	GUY	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	34	Southern Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	34	Southern Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	34	Southern Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	34	Southern Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	34	Southern Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	34	Southern Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	34	Southern Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	34	Southern Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	34	Southern Asia	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	340	Honduras	54.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				5	13	Central America	Country	-86.59974381	14.82243161	HND	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	340	Honduras	64.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				5	13	Central America	Country	-86.59974381	14.82243161	HND	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	340	Honduras	60.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	13	Central America	Country	-86.59974381	14.82243161	HND	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	348	Hungary	72.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	151	Eastern Europe	Country	19.41221519	47.1651448	HUN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	348	Hungary	71.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	151	Eastern Europe	Country	19.41221519	47.1651448	HUN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	348	Hungary	71.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	151	Eastern Europe	Country	19.41221519	47.1651448	HUN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	348	Hungary	70.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	151	Eastern Europe	Country	19.41221519	47.1651448	HUN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	35	South-Eastern Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	35	South-Eastern Asia	4.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	35	South-Eastern Asia	4.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	35	South-Eastern Asia	5.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	35	South-Eastern Asia	4.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	35	South-Eastern Asia	4.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	35	South-Eastern Asia	9.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	35	South-Eastern Asia	6.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	35	South-Eastern Asia	4.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				3	142	Asia	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	352	Iceland	92.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	154	Northern Europe	Country	-19.02116966	64.79134763	ISL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	352	Iceland	90.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	154	Northern Europe	Country	-19.02116966	64.79134763	ISL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	352	Iceland	89.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	154	Northern Europe	Country	-19.02116966	64.79134763	ISL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	352	Iceland	88.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	154	Northern Europe	Country	-19.02116966	64.79134763	ISL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	352	Iceland	90.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	154	Northern Europe	Country	-19.02116966	64.79134763	ISL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	352	Iceland	88.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	154	Northern Europe	Country	-19.02116966	64.79134763	ISL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	352	Iceland	85.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	154	Northern Europe	Country	-19.02116966	64.79134763	ISL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	36	Australia	71.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	53	Australia and New Zealand	Country	134.3499412	-25.57717202	AUS	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	36	Australia	72.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	53	Australia and New Zealand	Country	134.3499412	-25.57717202	AUS	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	36	Australia	74.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	53	Australia and New Zealand	Country	134.3499412	-25.57717202	AUS	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	36	Australia	78.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	53	Australia and New Zealand	Country	134.3499412	-25.57717202	AUS	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	36	Australia	79.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	53	Australia and New Zealand	Country	134.3499412	-25.57717202	AUS	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	36	Australia	80.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	53	Australia and New Zealand	Country	134.3499412	-25.57717202	AUS	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	36	Australia	80.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	53	Australia and New Zealand	Country	134.3499412	-25.57717202	AUS	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	360	Indonesia	2.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	35	South-Eastern Asia	Country	113.9174	-0.994582204	IDN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	360	Indonesia	0.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	35	South-Eastern Asia	Country	113.9174	-0.994582204	IDN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	372	Ireland	81.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	154	Northern Europe	Country	-7.121425272	53.25274054	IRL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	372	Ireland	84.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	154	Northern Europe	Country	-7.121425272	53.25274054	IRL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	372	Ireland	87.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	154	Northern Europe	Country	-7.121425272	53.25274054	IRL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	372	Ireland	86.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	154	Northern Europe	Country	-7.121425272	53.25274054	IRL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	372	Ireland	73.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	154	Northern Europe	Country	-7.121425272	53.25274054	IRL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	372	Ireland	52.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	154	Northern Europe	Country	-7.121425272	53.25274054	IRL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	372	Ireland	62.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	154	Northern Europe	Country	-7.121425272	53.25274054	IRL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	376	Israel	50.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	145	Western Asia	Country	34.62277992	31.06164552	ISR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	376	Israel	50.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	145	Western Asia	Country	34.62277992	31.06164552	ISR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	380	Italy	44.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				4	39	Southern Europe	Country	12.57022427	42.79917282	ITA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	380	Italy	52.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				4	39	Southern Europe	Country	12.57022427	42.79917282	ITA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	380	Italy	55.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	39	Southern Europe	Country	12.57022427	42.79917282	ITA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	380	Italy	56.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	39	Southern Europe	Country	12.57022427	42.79917282	ITA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	380	Italy	50.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	39	Southern Europe	Country	12.57022427	42.79917282	ITA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	380	Italy	56.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	39	Southern Europe	Country	12.57022427	42.79917282	ITA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	380	Italy	53.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	39	Southern Europe	Country	12.57022427	42.79917282	ITA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	380	Italy	49.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	39	Southern Europe	Country	12.57022427	42.79917282	ITA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	380	Italy	40.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	39	Southern Europe	Country	12.57022427	42.79917282	ITA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	388	Jamaica	8.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	29	Caribbean	Country	-77.31068409	18.15616857	JAM	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	39	Southern Europe	35.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	39	Southern Europe	40.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	39	Southern Europe	42.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	39	Southern Europe	43.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	39	Southern Europe	41.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	39	Southern Europe	45.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	39	Southern Europe	45.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	39	Southern Europe	46.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	39	Southern Europe	43.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				3	150	Europe	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	392	Japan	15.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	30	Eastern Asia	Country	139.2716103	36.6554539	JPN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	392	Japan	1.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	30	Eastern Asia	Country	139.2716103	36.6554539	JPN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	392	Japan	0.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	30	Eastern Asia	Country	139.2716103	36.6554539	JPN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	392	Japan	0.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	30	Eastern Asia	Country	139.2716103	36.6554539	JPN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	392	Japan	0.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	30	Eastern Asia	Country	139.2716103	36.6554539	JPN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	392	Japan	0.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	30	Eastern Asia	Country	139.2716103	36.6554539	JPN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	410	Republic of Korea	1.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	30	Eastern Asia	Country	127.8610254	36.45201023	KOR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	410	Republic of Korea	49.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	30	Eastern Asia	Country	127.8610254	36.45201023	KOR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	410	Republic of Korea	62.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	30	Eastern Asia	Country	127.8610254	36.45201023	KOR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	419	Latin America and the Caribbean	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				3	19	Americas	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	419	Latin America and the Caribbean	2.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				3	19	Americas	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	419	Latin America and the Caribbean	9.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				3	19	Americas	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	419	Latin America and the Caribbean	28.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				3	19	Americas	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	419	Latin America and the Caribbean	28.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				3	19	Americas	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	419	Latin America and the Caribbean	35.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				3	19	Americas	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	419	Latin America and the Caribbean	55.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				3	19	Americas	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	419	Latin America and the Caribbean	60.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				3	19	Americas	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	419	Latin America and the Caribbean	61.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				3	19	Americas	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	428	Latvia	71.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				4	154	Northern Europe	Country	26.42461876	56.64196636	LVA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	428	Latvia	62.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	154	Northern Europe	Country	26.42461876	56.64196636	LVA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	428	Latvia	65.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	154	Northern Europe	Country	26.42461876	56.64196636	LVA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	428	Latvia	60.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	154	Northern Europe	Country	26.42461876	56.64196636	LVA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	428	Latvia	55.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	154	Northern Europe	Country	26.42461876	56.64196636	LVA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	428	Latvia	45.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	154	Northern Europe	Country	26.42461876	56.64196636	LVA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	428	Latvia	46.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	154	Northern Europe	Country	26.42461876	56.64196636	LVA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	428	Latvia	53.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	154	Northern Europe	Country	26.42461876	56.64196636	LVA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	432	Landlocked developing countries (LLDCs)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	432	Landlocked developing countries (LLDCs)	2.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	432	Landlocked developing countries (LLDCs)	2.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	432	Landlocked developing countries (LLDCs)	3.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	432	Landlocked developing countries (LLDCs)	3.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	432	Landlocked developing countries (LLDCs)	3.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	432	Landlocked developing countries (LLDCs)	6.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	432	Landlocked developing countries (LLDCs)	10.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	432	Landlocked developing countries (LLDCs)	12.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	440	Lithuania	20.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	154	Northern Europe	Country	23.90517807	55.33680309	LTU	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	440	Lithuania	45.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	154	Northern Europe	Country	23.90517807	55.33680309	LTU	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	442	Luxembourg	16.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				4	155	Western Europe	Country	6.092656563	49.77679538	LUX	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	442	Luxembourg	19.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				4	155	Western Europe	Country	6.092656563	49.77679538	LUX	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	442	Luxembourg	20.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	155	Western Europe	Country	6.092656563	49.77679538	LUX	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	442	Luxembourg	20.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	155	Western Europe	Country	6.092656563	49.77679538	LUX	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	442	Luxembourg	9.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	155	Western Europe	Country	6.092656563	49.77679538	LUX	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	442	Luxembourg	14.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	155	Western Europe	Country	6.092656563	49.77679538	LUX	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	442	Luxembourg	14.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	155	Western Europe	Country	6.092656563	49.77679538	LUX	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	442	Luxembourg	14.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	155	Western Europe	Country	6.092656563	49.77679538	LUX	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	442	Luxembourg	14.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	155	Western Europe	Country	6.092656563	49.77679538	LUX	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	458	Malaysia	80.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				4	35	South-Eastern Asia	Country	116.8346314	5.452415309	MYS	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	458	Malaysia	83.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	35	South-Eastern Asia	Country	116.8346314	5.452415309	MYS	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	458	Malaysia	90.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	35	South-Eastern Asia	Country	116.8346314	5.452415309	MYS	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	458	Malaysia	85.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	35	South-Eastern Asia	Country	116.8346314	5.452415309	MYS	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	458	Malaysia	85.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	35	South-Eastern Asia	Country	116.8346314	5.452415309	MYS	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	458	Malaysia	84.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	35	South-Eastern Asia	Country	116.8346314	5.452415309	MYS	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	458	Malaysia	97.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	35	South-Eastern Asia	Country	116.8346314	5.452415309	MYS	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	458	Malaysia	83.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	35	South-Eastern Asia	Country	116.8346314	5.452415309	MYS	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	470	Malta	31.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	39	Southern Europe	Country	14.44617519	35.89194275	MLT	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	470	Malta	25.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	39	Southern Europe	Country	14.44617519	35.89194275	MLT	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	470	Malta	99.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	39	Southern Europe	Country	14.44617519	35.89194275	MLT	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	470	Malta	85.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	39	Southern Europe	Country	14.44617519	35.89194275	MLT	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	470	Malta	82.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	39	Southern Europe	Country	14.44617519	35.89194275	MLT	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	470	Malta	78.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	39	Southern Europe	Country	14.44617519	35.89194275	MLT	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	470	Malta	80.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	39	Southern Europe	Country	14.44617519	35.89194275	MLT	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	480	Mauritius	76.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				5	14	Eastern Africa	Country	57.568022	-20.28581998	MUS	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	480	Mauritius	80.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	14	Eastern Africa	Country	57.568022	-20.28581998	MUS	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	484	Mexico	4.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				5	13	Central America	Country	-102.5148166	23.93378032	MEX	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	484	Mexico	99.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				5	13	Central America	Country	-102.5148166	23.93378032	MEX	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	484	Mexico	99.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				5	13	Central America	Country	-102.5148166	23.93378032	MEX	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	484	Mexico	93.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				5	13	Central America	Country	-102.5148166	23.93378032	MEX	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	484	Mexico	99.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				5	13	Central America	Country	-102.5148166	23.93378032	MEX	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	484	Mexico	99.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				5	13	Central America	Country	-102.5148166	23.93378032	MEX	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	484	Mexico	98.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	13	Central America	Country	-102.5148166	23.93378032	MEX	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	485	Western Asia (exc. Armenia, Azerbaijan, Cyprus, Israel and Georgia)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	485	Western Asia (exc. Armenia, Azerbaijan, Cyprus, Israel and Georgia)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	485	Western Asia (exc. Armenia, Azerbaijan, Cyprus, Israel and Georgia)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	485	Western Asia (exc. Armenia, Azerbaijan, Cyprus, Israel and Georgia)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	485	Western Asia (exc. Armenia, Azerbaijan, Cyprus, Israel and Georgia)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	485	Western Asia (exc. Armenia, Azerbaijan, Cyprus, Israel and Georgia)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	485	Western Asia (exc. Armenia, Azerbaijan, Cyprus, Israel and Georgia)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	485	Western Asia (exc. Armenia, Azerbaijan, Cyprus, Israel and Georgia)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	485	Western Asia (exc. Armenia, Azerbaijan, Cyprus, Israel and Georgia)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	5	South America	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	5	South America	3.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	5	South America	11.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	5	South America	12.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	5	South America	12.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	5	South America	24.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	5	South America	51.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	5	South America	58.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	5	South America	58.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	419	Latin America and the Caribbean	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	51	Armenia	2.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	145	Western Asia	Country	44.93839317	40.29499741	ARM	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	513	Europe and Northern America	23.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	513	Europe and Northern America	27.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	513	Europe and Northern America	28.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	513	Europe and Northern America	29.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	513	Europe and Northern America	30.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	513	Europe and Northern America	34.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	513	Europe and Northern America	35.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	513	Europe and Northern America	37.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	513	Europe and Northern America	35.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	514	Developed Regions	20.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	514	Developed Regions	24.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	514	Developed Regions	27.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	514	Developed Regions	29.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	514	Developed Regions	28.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	514	Developed Regions	32.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	514	Developed Regions	33.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	514	Developed Regions	35.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	514	Developed Regions	34.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	515	Developing Regions	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	515	Developing Regions	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	515	Developing Regions	2.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	515	Developing Regions	4.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	515	Developing Regions	4.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	515	Developing Regions	5.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	515	Developing Regions	8.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	515	Developing Regions	8.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	515	Developing Regions	9.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	518	Eastern Asia (excluding Japan)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	518	Eastern Asia (excluding Japan)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	518	Eastern Asia (excluding Japan)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	518	Eastern Asia (excluding Japan)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	518	Eastern Asia (excluding Japan)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	518	Eastern Asia (excluding Japan)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	518	Eastern Asia (excluding Japan)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	518	Eastern Asia (excluding Japan)	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	518	Eastern Asia (excluding Japan)	2.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	52	Barbados	12.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				5	29	Caribbean	Country	-59.5346489	13.13648273	BRB	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	52	Barbados	29.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				5	29	Caribbean	Country	-59.5346489	13.13648273	BRB	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	52	Barbados	14.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				5	29	Caribbean	Country	-59.5346489	13.13648273	BRB	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	52	Barbados	14.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				5	29	Caribbean	Country	-59.5346489	13.13648273	BRB	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	52	Barbados	24.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	29	Caribbean	Country	-59.5346489	13.13648273	BRB	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	528	Netherlands	52.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				4	155	Western Europe	Country	5.331480568	51.86728884	NLD	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	528	Netherlands	56.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				4	155	Western Europe	Country	5.331480568	51.86728884	NLD	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	528	Netherlands	58.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	155	Western Europe	Country	5.331480568	51.86728884	NLD	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	528	Netherlands	58.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	155	Western Europe	Country	5.331480568	51.86728884	NLD	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	528	Netherlands	61.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	155	Western Europe	Country	5.331480568	51.86728884	NLD	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	528	Netherlands	61.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	155	Western Europe	Country	5.331480568	51.86728884	NLD	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	528	Netherlands	53.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	155	Western Europe	Country	5.331480568	51.86728884	NLD	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	528	Netherlands	45.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	155	Western Europe	Country	5.331480568	51.86728884	NLD	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	528	Netherlands	45.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	155	Western Europe	Country	5.331480568	51.86728884	NLD	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	53	Australia and New Zealand	8.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	53	Australia and New Zealand	8.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	53	Australia and New Zealand	69.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	53	Australia and New Zealand	70.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	53	Australia and New Zealand	72.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	53	Australia and New Zealand	75.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	53	Australia and New Zealand	76.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	53	Australia and New Zealand	76.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	53	Australia and New Zealand	76.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	54	Melanesia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	54	Melanesia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	54	Melanesia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	54	Melanesia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	54	Melanesia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	54	Melanesia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	54	Melanesia	3.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	54	Melanesia	3.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	54	Melanesia	3.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	543	Oceania (exc. Australia and New Zealand)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	543	Oceania (exc. Australia and New Zealand)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	543	Oceania (exc. Australia and New Zealand)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	543	Oceania (exc. Australia and New Zealand)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	543	Oceania (exc. Australia and New Zealand)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	543	Oceania (exc. Australia and New Zealand)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	543	Oceania (exc. Australia and New Zealand)	4.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	543	Oceania (exc. Australia and New Zealand)	4.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	543	Oceania (exc. Australia and New Zealand)	4.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	554	New Zealand	45.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				4	53	Australia and New Zealand	Country	170.4755673	-43.98721568	NZL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	554	New Zealand	44.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				4	53	Australia and New Zealand	Country	170.4755673	-43.98721568	NZL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	554	New Zealand	54.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	53	Australia and New Zealand	Country	170.4755673	-43.98721568	NZL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	554	New Zealand	57.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	53	Australia and New Zealand	Country	170.4755673	-43.98721568	NZL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	554	New Zealand	58.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	53	Australia and New Zealand	Country	170.4755673	-43.98721568	NZL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	554	New Zealand	55.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	53	Australia and New Zealand	Country	170.4755673	-43.98721568	NZL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	554	New Zealand	59.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	53	Australia and New Zealand	Country	170.4755673	-43.98721568	NZL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	554	New Zealand	56.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	53	Australia and New Zealand	Country	170.4755673	-43.98721568	NZL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	554	New Zealand	58.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	53	Australia and New Zealand	Country	170.4755673	-43.98721568	NZL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	56	Belgium	61.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	155	Western Europe	Country	4.660976456	50.64104975	BEL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	56	Belgium	66.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	155	Western Europe	Country	4.660976456	50.64104975	BEL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	56	Belgium	66.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	155	Western Europe	Country	4.660976456	50.64104975	BEL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	56	Belgium	66.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	155	Western Europe	Country	4.660976456	50.64104975	BEL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	57	Micronesia	8.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	57	Micronesia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	57	Micronesia	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	57	Micronesia	3.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	57	Micronesia	3.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	57	Micronesia	6.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	57	Micronesia	8.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	57	Micronesia	31.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	57	Micronesia	31.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	578	Norway	56.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				4	154	Northern Europe	Country	11.47846389	61.34311134	NOR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	578	Norway	72.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				4	154	Northern Europe	Country	11.47846389	61.34311134	NOR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	578	Norway	72.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	154	Northern Europe	Country	11.47846389	61.34311134	NOR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	578	Norway	74.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	154	Northern Europe	Country	11.47846389	61.34311134	NOR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	578	Norway	78.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	154	Northern Europe	Country	11.47846389	61.34311134	NOR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	578	Norway	81.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	154	Northern Europe	Country	11.47846389	61.34311134	NOR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	578	Norway	83.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	154	Northern Europe	Country	11.47846389	61.34311134	NOR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	578	Norway	84.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	154	Northern Europe	Country	11.47846389	61.34311134	NOR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	578	Norway	85.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	154	Northern Europe	Country	11.47846389	61.34311134	NOR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	583	Micronesia (Federated States of)	67.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	57	Micronesia	Country	158.225216	6.880670092	FSM	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	583	Micronesia (Federated States of)	60.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	57	Micronesia	Country	158.225216	6.880670092	FSM	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	584	Marshall Islands	45.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				4	57	Micronesia	Country	171.0839119	7.110213497	MHL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	584	Marshall Islands	3.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	57	Micronesia	Country	171.0839119	7.110213497	MHL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	584	Marshall Islands	10.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	57	Micronesia	Country	171.0839119	7.110213497	MHL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	584	Marshall Islands	13.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	57	Micronesia	Country	171.0839119	7.110213497	MHL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	584	Marshall Islands	22.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	57	Micronesia	Country	171.0839119	7.110213497	MHL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	584	Marshall Islands	31.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	57	Micronesia	Country	171.0839119	7.110213497	MHL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	584	Marshall Islands	21.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	57	Micronesia	Country	171.0839119	7.110213497	MHL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	584	Marshall Islands	28.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	57	Micronesia	Country	171.0839119	7.110213497	MHL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	585	Palau	8.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				4	57	Micronesia	Country	134.5733878	7.502307591	PLW	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	585	Palau	4.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				4	57	Micronesia	Country	134.5733878	7.502307591	PLW	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	585	Palau	11.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	57	Micronesia	Country	134.5733878	7.502307591	PLW	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	585	Palau	16.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	57	Micronesia	Country	134.5733878	7.502307591	PLW	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	585	Palau	19.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	57	Micronesia	Country	134.5733878	7.502307591	PLW	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	585	Palau	23.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	57	Micronesia	Country	134.5733878	7.502307591	PLW	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	585	Palau	30.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	57	Micronesia	Country	134.5733878	7.502307591	PLW	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	585	Palau	35.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	57	Micronesia	Country	134.5733878	7.502307591	PLW	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	585	Palau	47.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	57	Micronesia	Country	134.5733878	7.502307591	PLW	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	591	Panama	64.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				5	13	Central America	Country	-81.26616623	8.450965746	PAN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	591	Panama	78.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				5	13	Central America	Country	-81.26616623	8.450965746	PAN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	591	Panama	77.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				5	13	Central America	Country	-81.26616623	8.450965746	PAN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	591	Panama	74.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				5	13	Central America	Country	-81.26616623	8.450965746	PAN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	591	Panama	80.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				5	13	Central America	Country	-81.26616623	8.450965746	PAN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	591	Panama	58.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				5	13	Central America	Country	-81.26616623	8.450965746	PAN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	591	Panama	52.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				5	13	Central America	Country	-81.26616623	8.450965746	PAN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	591	Panama	68.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				5	13	Central America	Country	-81.26616623	8.450965746	PAN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	591	Panama	68.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	13	Central America	Country	-81.26616623	8.450965746	PAN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	600	Paraguay	71.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				5	5	South America	Country	-60.54854225	-21.70216237	PRY	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	600	Paraguay	68.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				5	5	South America	Country	-60.54854225	-21.70216237	PRY	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	600	Paraguay	65.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				5	5	South America	Country	-60.54854225	-21.70216237	PRY	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	600	Paraguay	62.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				5	5	South America	Country	-60.54854225	-21.70216237	PRY	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	600	Paraguay	55.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				5	5	South America	Country	-60.54854225	-21.70216237	PRY	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	600	Paraguay	56.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	5	South America	Country	-60.54854225	-21.70216237	PRY	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	604	Peru	32.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				5	5	South America	Country	-71.82093277	-13.58939705	PER	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	604	Peru	19.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				5	5	South America	Country	-71.82093277	-13.58939705	PER	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	604	Peru	7.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				5	5	South America	Country	-71.82093277	-13.58939705	PER	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	604	Peru	3.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				5	5	South America	Country	-71.82093277	-13.58939705	PER	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	604	Peru	53.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				5	5	South America	Country	-71.82093277	-13.58939705	PER	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	604	Peru	58.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				5	5	South America	Country	-71.82093277	-13.58939705	PER	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	604	Peru	63.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				5	5	South America	Country	-71.82093277	-13.58939705	PER	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	604	Peru	68.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	5	South America	Country	-71.82093277	-13.58939705	PER	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	608	Philippines	23.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	35	South-Eastern Asia	Country	120.8601418	14.16591706	PHL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	608	Philippines	0.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	35	South-Eastern Asia	Country	120.8601418	14.16591706	PHL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	608	Philippines	0.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	35	South-Eastern Asia	Country	120.8601418	14.16591706	PHL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	61	Polynesia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	61	Polynesia	4.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	61	Polynesia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	61	Polynesia	5.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	61	Polynesia	4.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	61	Polynesia	4.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	61	Polynesia	3.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	61	Polynesia	4.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	61	Polynesia	4.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				3	9	Oceania	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	62	Central and Southern Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	62	Central and Southern Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	62	Central and Southern Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	62	Central and Southern Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	62	Central and Southern Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	62	Central and Southern Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	62	Central and Southern Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	62	Central and Southern Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	62	Central and Southern Asia	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	620	Portugal	80.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	39	Southern Europe	Country	-7.961599811	39.68509315	PRT	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	64	Bhutan	87.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				4	34	Southern Asia	Country	90.45098484	27.39598568	BTN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	64	Bhutan	68.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				4	34	Southern Asia	Country	90.45098484	27.39598568	BTN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	64	Bhutan	72.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	34	Southern Asia	Country	90.45098484	27.39598568	BTN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	64	Bhutan	70.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	34	Southern Asia	Country	90.45098484	27.39598568	BTN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	64	Bhutan	94.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	34	Southern Asia	Country	90.45098484	27.39598568	BTN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	64	Bhutan	94.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	34	Southern Asia	Country	90.45098484	27.39598568	BTN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	64	Bhutan	96.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	34	Southern Asia	Country	90.45098484	27.39598568	BTN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	64	Bhutan	89.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	34	Southern Asia	Country	90.45098484	27.39598568	BTN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	646	Rwanda	70.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				5	14	Eastern Africa	Country	29.92310194	-1.999842114	RWA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	646	Rwanda	71.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				5	14	Eastern Africa	Country	29.92310194	-1.999842114	RWA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	646	Rwanda	72.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				5	14	Eastern Africa	Country	29.92310194	-1.999842114	RWA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	646	Rwanda	74.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				5	14	Eastern Africa	Country	29.92310194	-1.999842114	RWA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	646	Rwanda	75.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				5	14	Eastern Africa	Country	29.92310194	-1.999842114	RWA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	646	Rwanda	83.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				5	14	Eastern Africa	Country	29.92310194	-1.999842114	RWA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	646	Rwanda	80.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				5	14	Eastern Africa	Country	29.92310194	-1.999842114	RWA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	646	Rwanda	84.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	14	Eastern Africa	Country	29.92310194	-1.999842114	RWA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	670	Saint Vincent and the Grenadines	3.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	29	Caribbean	Country	-61.19024321	13.24627968	VCT	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	674	San Marino	21.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	39	Southern Europe	Country	12.46329038	43.93841766	SMR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	674	San Marino	18.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	39	Southern Europe	Country	12.46329038	43.93841766	SMR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	674	San Marino	16.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	39	Southern Europe	Country	12.46329038	43.93841766	SMR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	674	San Marino	17.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	39	Southern Europe	Country	12.46329038	43.93841766	SMR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	674	San Marino	12.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	39	Southern Europe	Country	12.46329038	43.93841766	SMR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	674	San Marino	4.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	39	Southern Europe	Country	12.46329038	43.93841766	SMR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	674	San Marino	16.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	39	Southern Europe	Country	12.46329038	43.93841766	SMR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	678	Sao Tome and Principe	95.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	17	Middle Africa	Country	6.609772265	0.241554875	STP	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	68	Bolivia (Plurinational State of)	62.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				5	5	South America	Country	-64.66224284	-16.71273412	BOL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	68	Bolivia (Plurinational State of)	60.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	5	South America	Country	-64.66224284	-16.71273412	BOL	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	690	Seychelles	89.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				5	14	Eastern Africa	Country	55.46561591	-4.678053059	SYC	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	690	Seychelles	99.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				5	14	Eastern Africa	Country	55.46561591	-4.678053059	SYC	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	690	Seychelles	99.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				5	14	Eastern Africa	Country	55.46561591	-4.678053059	SYC	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	690	Seychelles	89.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				5	14	Eastern Africa	Country	55.46561591	-4.678053059	SYC	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	690	Seychelles	99.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	14	Eastern Africa	Country	55.46561591	-4.678053059	SYC	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	702	Singapore	0.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	35	South-Eastern Asia	Country	103.8107883	1.361009155	SGP	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	702	Singapore	0.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	35	South-Eastern Asia	Country	103.8107883	1.361009155	SGP	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	702	Singapore	0.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	35	South-Eastern Asia	Country	103.8107883	1.361009155	SGP	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	702	Singapore	0.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	35	South-Eastern Asia	Country	103.8107883	1.361009155	SGP	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	702	Singapore	0.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	35	South-Eastern Asia	Country	103.8107883	1.361009155	SGP	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	702	Singapore	0.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	35	South-Eastern Asia	Country	103.8107883	1.361009155	SGP	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	702	Singapore	0.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	35	South-Eastern Asia	Country	103.8107883	1.361009155	SGP	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	705	Slovenia	44.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				4	39	Southern Europe	Country	14.82209486	46.11958061	SVN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	705	Slovenia	47.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				4	39	Southern Europe	Country	14.82209486	46.11958061	SVN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	705	Slovenia	51.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	39	Southern Europe	Country	14.82209486	46.11958061	SVN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	705	Slovenia	39.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	39	Southern Europe	Country	14.82209486	46.11958061	SVN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	705	Slovenia	44.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	39	Southern Europe	Country	14.82209486	46.11958061	SVN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	705	Slovenia	40.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	39	Southern Europe	Country	14.82209486	46.11958061	SVN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	705	Slovenia	40.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	39	Southern Europe	Country	14.82209486	46.11958061	SVN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	705	Slovenia	41.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	39	Southern Europe	Country	14.82209486	46.11958061	SVN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	705	Slovenia	45.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	39	Southern Europe	Country	14.82209486	46.11958061	SVN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	710	South Africa	63.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				5	18	Southern Africa	Country	24.67184355	-29.99957544	ZAF	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	710	South Africa	60.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				5	18	Southern Africa	Country	24.67184355	-29.99957544	ZAF	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	710	South Africa	61.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				5	18	Southern Africa	Country	24.67184355	-29.99957544	ZAF	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	710	South Africa	57.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				5	18	Southern Africa	Country	24.67184355	-29.99957544	ZAF	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	710	South Africa	57.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	18	Southern Africa	Country	24.67184355	-29.99957544	ZAF	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	72	Botswana	51.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				5	18	Southern Africa	Country	23.81380223	-22.18810073	BWA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	72	Botswana	82.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				5	18	Southern Africa	Country	23.81380223	-22.18810073	BWA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	72	Botswana	82.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				5	18	Southern Africa	Country	23.81380223	-22.18810073	BWA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	72	Botswana	82.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	18	Southern Africa	Country	23.81380223	-22.18810073	BWA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	722	Small island developing States (SIDS)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	722	Small island developing States (SIDS)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	722	Small island developing States (SIDS)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	722	Small island developing States (SIDS)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	722	Small island developing States (SIDS)	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	722	Small island developing States (SIDS)	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	722	Small island developing States (SIDS)	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	722	Small island developing States (SIDS)	9.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	722	Small island developing States (SIDS)	5.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	724	Spain	64.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				4	39	Southern Europe	Country	-3.554078296	40.39211472	ESP	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	724	Spain	67.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				4	39	Southern Europe	Country	-3.554078296	40.39211472	ESP	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	724	Spain	71.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	39	Southern Europe	Country	-3.554078296	40.39211472	ESP	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	724	Spain	74.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	39	Southern Europe	Country	-3.554078296	40.39211472	ESP	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	724	Spain	72.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	39	Southern Europe	Country	-3.554078296	40.39211472	ESP	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	724	Spain	78.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	39	Southern Europe	Country	-3.554078296	40.39211472	ESP	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	724	Spain	81.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	39	Southern Europe	Country	-3.554078296	40.39211472	ESP	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	724	Spain	87.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	39	Southern Europe	Country	-3.554078296	40.39211472	ESP	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	724	Spain	68.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	39	Southern Europe	Country	-3.554078296	40.39211472	ESP	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	738	Sub-Saharan Africa (inc. Sudan)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	738	Sub-Saharan Africa (inc. Sudan)	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	738	Sub-Saharan Africa (inc. Sudan)	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	738	Sub-Saharan Africa (inc. Sudan)	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	738	Sub-Saharan Africa (inc. Sudan)	4.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	738	Sub-Saharan Africa (inc. Sudan)	4.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	738	Sub-Saharan Africa (inc. Sudan)	5.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	738	Sub-Saharan Africa (inc. Sudan)	6.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	738	Sub-Saharan Africa (inc. Sudan)	7.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	740	Suriname	41.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				5	5	South America	Country	-55.90626394	4.132603197	SUR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	740	Suriname	70.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				5	5	South America	Country	-55.90626394	4.132603197	SUR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	740	Suriname	38.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				5	5	South America	Country	-55.90626394	4.132603197	SUR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	740	Suriname	38.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				5	5	South America	Country	-55.90626394	4.132603197	SUR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	740	Suriname	38.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	5	South America	Country	-55.90626394	4.132603197	SUR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	746	Northern Africa (exc. Sudan)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	746	Northern Africa (exc. Sudan)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	746	Northern Africa (exc. Sudan)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	746	Northern Africa (exc. Sudan)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	746	Northern Africa (exc. Sudan)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	746	Northern Africa (exc. Sudan)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	746	Northern Africa (exc. Sudan)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	746	Northern Africa (exc. Sudan)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	746	Northern Africa (exc. Sudan)	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				1			Group					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	747	Northern Africa and Western Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	747	Northern Africa and Western Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	747	Northern Africa and Western Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	747	Northern Africa and Western Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	747	Northern Africa and Western Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	747	Northern Africa and Western Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	747	Northern Africa and Western Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	747	Northern Africa and Western Asia	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	747	Northern Africa and Western Asia	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	752	Sweden	73.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	154	Northern Europe	Country	14.3775338	60.60103109	SWE	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	752	Sweden	72.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	154	Northern Europe	Country	14.3775338	60.60103109	SWE	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	752	Sweden	75.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	154	Northern Europe	Country	14.3775338	60.60103109	SWE	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	753	Eastern and South-Eastern Asia	0.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	753	Eastern and South-Eastern Asia	1.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	753	Eastern and South-Eastern Asia	2.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	753	Eastern and South-Eastern Asia	2.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	753	Eastern and South-Eastern Asia	2.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	753	Eastern and South-Eastern Asia	2.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	753	Eastern and South-Eastern Asia	3.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	753	Eastern and South-Eastern Asia	3.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	753	Eastern and South-Eastern Asia	3.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	756	Switzerland	20.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				4	155	Western Europe	Country	8.223158	46.96617097	CHE	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	756	Switzerland	51.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				4	155	Western Europe	Country	8.223158	46.96617097	CHE	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	756	Switzerland	51.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	155	Western Europe	Country	8.223158	46.96617097	CHE	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	756	Switzerland	51.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	155	Western Europe	Country	8.223158	46.96617097	CHE	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	756	Switzerland	56.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	155	Western Europe	Country	8.223158	46.96617097	CHE	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	756	Switzerland	56.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	155	Western Europe	Country	8.223158	46.96617097	CHE	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	756	Switzerland	56.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	155	Western Europe	Country	8.223158	46.96617097	CHE	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	756	Switzerland	53.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	155	Western Europe	Country	8.223158	46.96617097	CHE	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	756	Switzerland	57.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	155	Western Europe	Country	8.223158	46.96617097	CHE	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	76	Brazil	15.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				5	5	South America	Country	-53.08432878	-10.77668561	BRA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	76	Brazil	66.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				5	5	South America	Country	-53.08432878	-10.77668561	BRA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	76	Brazil	76.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				5	5	South America	Country	-53.08432878	-10.77668561	BRA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	76	Brazil	69.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	5	South America	Country	-53.08432878	-10.77668561	BRA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	780	Trinidad and Tobago	8.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				5	29	Caribbean	Country	-61.29389504	10.41877263	TTO	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	780	Trinidad and Tobago	7.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				5	29	Caribbean	Country	-61.29389504	10.41877263	TTO	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	780	Trinidad and Tobago	6.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				5	29	Caribbean	Country	-61.29389504	10.41877263	TTO	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	780	Trinidad and Tobago	6.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				5	29	Caribbean	Country	-61.29389504	10.41877263	TTO	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	780	Trinidad and Tobago	12.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				5	29	Caribbean	Country	-61.29389504	10.41877263	TTO	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	780	Trinidad and Tobago	14.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	29	Caribbean	Country	-61.29389504	10.41877263	TTO	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	784	United Arab Emirates	26.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	145	Western Asia	Country	53.98279159	23.43322219	ARE	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	795	Turkmenistan	95.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	143	Central Asia	Country	58.9787665	40.0912346	TKM	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	795	Turkmenistan	95.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	143	Central Asia	Country	58.9787665	40.0912346	TKM	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	800	Uganda	31.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				5	14	Eastern Africa	Country	32.39100438	1.279557331	UGA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	800	Uganda	55.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				5	14	Eastern Africa	Country	32.39100438	1.279557331	UGA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	800	Uganda	71.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	14	Eastern Africa	Country	32.39100438	1.279557331	UGA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	807	North Macedonia	33.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				4	39	Southern Europe	Country	21.7007909	41.60048068	MKD	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	807	North Macedonia	47.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				4	39	Southern Europe	Country	21.7007909	41.60048068	MKD	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	807	North Macedonia	42.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	39	Southern Europe	Country	21.7007909	41.60048068	MKD	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	807	North Macedonia	34.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	39	Southern Europe	Country	21.7007909	41.60048068	MKD	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	807	North Macedonia	46.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	39	Southern Europe	Country	21.7007909	41.60048068	MKD	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	807	North Macedonia	30.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	39	Southern Europe	Country	21.7007909	41.60048068	MKD	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	807	North Macedonia	44.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	39	Southern Europe	Country	21.7007909	41.60048068	MKD	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	807	North Macedonia	38.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	39	Southern Europe	Country	21.7007909	41.60048068	MKD	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	807	North Macedonia	40.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	39	Southern Europe	Country	21.7007909	41.60048068	MKD	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	826	United Kingdom of Great Britain and Northern Ireland	78.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				4	154	Northern Europe	Country	-2.23830539	53.27691757	GBR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	826	United Kingdom of Great Britain and Northern Ireland	83.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				4	154	Northern Europe	Country	-2.23830539	53.27691757	GBR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	826	United Kingdom of Great Britain and Northern Ireland	94.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	154	Northern Europe	Country	-2.23830539	53.27691757	GBR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	826	United Kingdom of Great Britain and Northern Ireland	85.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	154	Northern Europe	Country	-2.23830539	53.27691757	GBR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	826	United Kingdom of Great Britain and Northern Ireland	85.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	154	Northern Europe	Country	-2.23830539	53.27691757	GBR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	826	United Kingdom of Great Britain and Northern Ireland	83.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	154	Northern Europe	Country	-2.23830539	53.27691757	GBR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	826	United Kingdom of Great Britain and Northern Ireland	82.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	154	Northern Europe	Country	-2.23830539	53.27691757	GBR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	826	United Kingdom of Great Britain and Northern Ireland	80.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	154	Northern Europe	Country	-2.23830539	53.27691757	GBR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	826	United Kingdom of Great Britain and Northern Ireland	80.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	154	Northern Europe	Country	-2.23830539	53.27691757	GBR	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	834	United Republic of Tanzania	15.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	14	Eastern Africa	Country	34.80521182	-6.265332606	TZA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	84	Belize	61.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				5	13	Central America	Country	-88.70199554	17.19965901	BLZ	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	84	Belize	63.5					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	13	Central America	Country	-88.70199554	17.19965901	BLZ	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	840	United States of America	31.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				4	21	Northern America	Country	-99.13830311	39.5277871	USA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	840	United States of America	37.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				4	21	Northern America	Country	-99.13830311	39.5277871	USA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	840	United States of America	35.3					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	21	Northern America	Country	-99.13830311	39.5277871	USA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	840	United States of America	39.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	21	Northern America	Country	-99.13830311	39.5277871	USA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	840	United States of America	41.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	21	Northern America	Country	-99.13830311	39.5277871	USA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	840	United States of America	44.1					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	21	Northern America	Country	-99.13830311	39.5277871	USA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	840	United States of America	45.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	21	Northern America	Country	-99.13830311	39.5277871	USA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	840	United States of America	50.7					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	21	Northern America	Country	-99.13830311	39.5277871	USA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	840	United States of America	46.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	21	Northern America	Country	-99.13830311	39.5277871	USA	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	858	Uruguay	25.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				5	5	South America	Country	-56.01387025	-32.8002838	URY	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	858	Uruguay	44.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				5	5	South America	Country	-56.01387025	-32.8002838	URY	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	858	Uruguay	43.2					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				5	5	South America	Country	-56.01387025	-32.8002838	URY	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	858	Uruguay	41.9					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				5	5	South America	Country	-56.01387025	-32.8002838	URY	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	9	Oceania	5.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2010				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	9	Oceania	5.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2011				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	9	Oceania	43.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	9	Oceania	43.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	9	Oceania	44.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	9	Oceania	46.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	9	Oceania	48.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	9	Oceania	48.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	9	Oceania	48.0					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				2	1	World	Region					
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	96	Brunei Darussalam	96.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2012				4	35	South-Eastern Asia	Country	114.6288563	4.49736984	BRN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	96	Brunei Darussalam	79.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2013				4	35	South-Eastern Asia	Country	114.6288563	4.49736984	BRN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	96	Brunei Darussalam	79.8					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2014				4	35	South-Eastern Asia	Country	114.6288563	4.49736984	BRN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	96	Brunei Darussalam	76.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2015				4	35	South-Eastern Asia	Country	114.6288563	4.49736984	BRN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	96	Brunei Darussalam	85.4					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2016				4	35	South-Eastern Asia	Country	114.6288563	4.49736984	BRN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	96	Brunei Darussalam	87.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2017				4	35	South-Eastern Asia	Country	114.6288563	4.49736984	BRN	1	1
SH_ACS_HPV	Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)	96	Brunei Darussalam	88.6					WHO and UNICEF HPV coverage estimates		E	Estimated data	PT	Percentage	G	Global	2018				4	35	South-Eastern Asia	Country	114.6288563	4.49736984	BRN	1	1
